- Home
- DIT vs SER Comparison
DIT vs SER Comparison
Compare DIT & SER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DIT
- SER
- Stock Information
- Founded
- DIT 1981
- SER 2017
- Country
- DIT United States
- SER United States
- Employees
- DIT N/A
- SER N/A
- Industry
- DIT Food Distributors
- SER Biotechnology: Pharmaceutical Preparations
- Sector
- DIT Consumer Discretionary
- SER Health Care
- Exchange
- DIT Nasdaq
- SER Nasdaq
- Market Cap
- DIT 70.4M
- SER 56.5M
- IPO Year
- DIT 1995
- SER 2018
- Fundamental
- Price
- DIT $115.99
- SER $5.11
- Analyst Decision
- DIT
- SER Strong Buy
- Analyst Count
- DIT 0
- SER 2
- Target Price
- DIT N/A
- SER $13.00
- AVG Volume (30 Days)
- DIT 374.0
- SER 326.5K
- Earning Date
- DIT 11-07-2025
- SER 08-11-2025
- Dividend Yield
- DIT 0.87%
- SER N/A
- EPS Growth
- DIT N/A
- SER N/A
- EPS
- DIT 2.14
- SER N/A
- Revenue
- DIT $2,251,684,195.00
- SER $130,000.00
- Revenue This Year
- DIT N/A
- SER N/A
- Revenue Next Year
- DIT N/A
- SER N/A
- P/E Ratio
- DIT $53.72
- SER N/A
- Revenue Growth
- DIT 7.64
- SER N/A
- 52 Week Low
- DIT $94.92
- SER $3.81
- 52 Week High
- DIT $163.75
- SER $10.28
- Technical
- Relative Strength Index (RSI)
- DIT 53.05
- SER 44.13
- Support Level
- DIT $111.50
- SER $5.00
- Resistance Level
- DIT $121.00
- SER $5.49
- Average True Range (ATR)
- DIT 3.96
- SER 0.53
- MACD
- DIT 0.26
- SER -0.01
- Stochastic Oscillator
- DIT 69.28
- SER 12.36
About DIT AMCON Distributing Company
Amcon Distributing Co is engaged in the wholesale and retail distribution of consumer products such as cigarettes, tobacco, confectionery, health food, and others. It operates in two segments: Wholesale distribution segment distributing consumer products to the retail outlets including convenience stores, grocery stores, liquor stores, drug stores and tobacco shops in the Central, Rocky Mountain, and Southern regions of the United States; and the Retail health food segment is a specialty retailer of natural/organic groceries and dietary supplements throughout the Midwest and Florida. The company earns a majority of the revenue from the Wholesale distribution segment.
About SER Serina Therapeutics Inc.
Serina Therapeutics Inc is a clinical-stage biotechnology company developing a pipeline of wholly-owned drug product candidates to treat neurological diseases and pain. Serina's POZ Platform delivery technology is engineered to provide control in drug loading and more precision in the rate of release of attached drugs, enabling the potential of certain challenging small molecules, while addressing the limitations of polyethylene glycol (PEG) and other biocompatible polymers. The Company has one reportable segment relating to the research and development of its POZ platform.